Compass Labs offer a test for HPV
Author: Katherine Pfaff
Compass Laboratory Services has developed an oral rinse to detect high-risk HPV in the oral cavity, OraGen HPV. The human papillomavirus (HPV) is linked to neck and head cancers. More than 25 million Americans are thought to have HPV. Specific subtypes of HPV are thought to increase cancer risk, making detection important.
OraGen HPV genotyping test is intended to detect strains of high-risk HPV. The test can detect HPV 16/18, which is thought to pose the greatest risk for developing head and neck cancer.
For info contact:
Compass Lab Services
Phone: 901.348.5774
Email: info@compasslabservices.com
Source: www.compasslabservices.com
Image credit: Compass Laboratory Services
Related articles
Products 05 November 2025
SimplyTest has launched a groundbreaking saliva-based test to detect high-risk strains of oral human papillomavirus (HPV), a major cause of oropharyngeal cancers.
Read more
Products 13 October 2026
New Resources Help Dental Exhibitors Evaluate Their Investment and Explore the Personify ShowFlow™ Trade Show Success System
News 13 October 2026
New patient apps extend The Aspen Group’s mission to remove barriers to care, giving patients greater visibility, convenience, and control from booking through treatment
Editorials 13 October 2026
The forerunner of what’s now Texas A&M College of Dentistry opened 120 years ago in Dallas with the mission of educating dentists to provide quality care to patients in North Texas
Oral pathology 13 October 2026
This peer-reviewed oral pathology article summarizes clinical evidence from Oral oncology (2026). It focuses on findings that may help dental professionals evaluate treatment decisions, patient...
Copyright © 2026 - All Rights Reserved
ISSN 2767-1178